These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29558725)

  • 1. A UHPLC-MS/MS-based method for the simultaneous monitoring of eight antiblastic drugs in plasma and urine of exposed healthcare workers.
    Izzo V; Charlier B; Bloise E; Pingeon M; Romano M; Finelli A; Vietri A; Conti V; Manzo V; Alfieri M; Filippelli A; Dal Piaz F
    J Pharm Biomed Anal; 2018 May; 154():245-251. PubMed ID: 29558725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A LC-MS/MS based methodology for the environmental monitoring of healthcare settings contaminated with antineoplastic agents.
    Charlier B; Coglianese A; De Rosa F; Cozzolino A; Boccia G; Borrelli A; Capunzo M; Genovese G; De Caro F; Filippelli A; Dal Piaz F; Izzo V
    J Public Health Res; 2023 Jan; 12(1):22799036231160629. PubMed ID: 36923326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly sensitive UHPLC-MS/MS method for urine biological monitoring of occupational exposure to anthracycline antineoplastic drugs and routine application.
    Villa A; Tremolet K; Martinez B; Da Silva Cacao O; Atgé B; Ducint D; Titier-Debeaupuis K; Verdun-Esquer C; Molimard M; Canal-Raffin M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1156():122305. PubMed ID: 32987297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers.
    Poupeau C; Tanguay C; Plante C; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2017 Jul; 23(5):323-332. PubMed ID: 27084515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment.
    Pretty JR; Connor TH; Spasojevic I; Kurtz KS; McLaurin JL; B'Hymer C; Debord DG
    J Oncol Pharm Pract; 2012 Mar; 18(1):23-36. PubMed ID: 21183556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings.
    Sabatini L; Barbieri A; Lodi V; Violante FS
    Med Lav; 2012; 103(5):394-401. PubMed ID: 23077799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of high performance liquid chromatographic-mass spectrometric urinary methods for anticancer drug exposure of health care workers.
    Mathias PI; Connor TH; B'Hymer C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():316-324. PubMed ID: 28654869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A surface wipe sampling and LC-MS/MS method for the simultaneous detection of six antineoplastic drugs commonly handled by healthcare workers.
    Jeronimo M; Colombo M; Astrakianakis G; Hon CY
    Anal Bioanal Chem; 2015 Sep; 407(23):7083-92. PubMed ID: 26141324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trace determination of anthracyclines in urine: a new high-performance liquid chromatography/tandem mass spectrometry method for assessing exposure of hospital personnel.
    Sottani C; Tranfo G; Bettinelli M; Faranda P; Spagnoli M; Minoia C
    Rapid Commun Mass Spectrom; 2004; 18(20):2426-36. PubMed ID: 15386628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological monitoring of occupational exposure to 5-fluorouracil: urinary α-fluoro-β-alanine assay by high performance liquid chromatography tandem mass spectrometry in health care personnel.
    Ndaw S; Denis F; Marsan P; d'Almeida A; Robert A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2630-4. PubMed ID: 20207593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly sensitive high-performance liquid chromatography/selective reaction monitoring mass spectrometry method for the determination of cyclophosphamide and ifosfamide in urine of health care workers exposed to antineoplastic agents.
    Sottani C; Tranfo G; Faranda P; Minoia C
    Rapid Commun Mass Spectrom; 2005; 19(19):2794-800. PubMed ID: 16144038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of an innovative high-throughput liquid chromatography-tandem mass spectrometry method for simultaneous analysis of 18 hazardous drugs to rule out accidental acute chemotherapy exposures in health care workers.
    Shu P; Zhao T; Wen B; Mendelsohn-Victor K; Sun D; Friese CR; Pai MP
    J Oncol Pharm Pract; 2020 Jun; 26(4):794-802. PubMed ID: 31483750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of low levels of methotrexate and cyclophosphamide in human urine by micro liquid chromatography/electrospray ionization tandem mass spectrometry.
    Barbieri A; Sabatini L; Indiveri P; Bonfiglioli R; Lodi V; Violante FS
    Rapid Commun Mass Spectrom; 2006; 20(12):1889-93. PubMed ID: 16715479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UHPLC-MS/MS method for the quantification of ultra-traces of irinotecan and its metabolites in red blood cells and plasma to detect caregivers' contamination.
    Rodier S; Saint-Lorant G; Since M; Lagadu S; Benoist H; Palix A; Guilloit JM; Faveyrial A; Divanon F; Delépée R
    Drug Test Anal; 2024 Feb; 16(2):236-246. PubMed ID: 37381704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation.
    Sottani C; Rinaldi P; Leoni E; Poggi G; Teragni C; Delmonte A; Minoia C
    Rapid Commun Mass Spectrom; 2008 Sep; 22(17):2645-59. PubMed ID: 18666202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineoplastic drug contamination in the urine of Canadian healthcare workers.
    Hon CY; Teschke K; Shen H; Demers PA; Venners S
    Int Arch Occup Environ Health; 2015 Oct; 88(7):933-41. PubMed ID: 25626912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of low- and high-risk operators handling irinotecan on the blood contamination of health care workers in oncology day care units.
    Pirot C; Benoist H; Lagadu S; Delépée R; Saint-Lorant G
    J Oncol Pharm Pract; 2023 Jun; 29(4):905-911. PubMed ID: 35382645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine biomonitoring of occupational exposure to methotrexate using a highly sensitive UHPLC-MS/MS method in MRM
    Villa A; Tremolet K; Martinez B; Petit M; Dascon X; Stanek J; Ducint D; Titier-Debeaupuis K; Verdun-Esquer C; Molimard M; Canal-Raffin M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1209():123411. PubMed ID: 35985163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.
    Hon CY; Teschke K; Demers PA; Venners S
    Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UPLC-MS/MS method for simultaneous determination of cyclophosphamide, docetaxel, doxorubicin and 5-fluorouracil in surface samples.
    da Silva CB; Julio IP; Donadel GE; Martins I
    J Pharmacol Toxicol Methods; 2016; 82():68-73. PubMed ID: 27521053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.